세계 모기 매개성 질환 시장 : 질병 유형별, 치료 유형별, 최종 사용자별, 지역별

Global mosquito borne disease market size is expected to reach US$ 5.10 Bn by 2030, from US$ 3.11 Bn in 2023, exhibiting a CAGR of 7.3% during the forecast period.

Figure 1. Global Mosquito Borne Disease Market Share (%), By Region, 2023

Mosquito borne disease have been a significant public health concern in several parts of the world. These diseases, transmitted through the bite of infected mosquitoes, pose a threat to human lives, and are responsible for a considerable disease burden. One innovative solution to combat mosquito borne diseases is the development of a stone slab that repels mosquitoes, and thus, offering protection to individuals. This stone slab acts as an effective barrier against mosquitoes, reducing the risk of diseases such as malaria, dengue fever, and Zika virus.

Market Dynamics:

Global mosquito borne disease market is expected to witness significant growth in the near future due to increasing incidence of mosquito-borne diseases, coupled with growing awareness about their impact on public health. Governments and healthcare organizations are investing heavily in research and development to develop effective diagnostics and treatment options. Technological advancements in mosquito control methods such as insecticides and mosquito traps are further contributing to market growth. However, there are also several challenges that need to be addressed. One of the major restraints for the market growth is the lack of awareness and access to healthcare facilities, particularly in developing countries. Limited healthcare infrastructure, inadequate funding, and poor sanitation contribute to the spread of mosquito-borne diseases. Furthermore, the development of drug resistance in mosquitoes and the complexity of vaccine development pose significant challenges to the market.

Despite these challenges, there are significant opportunities in the global mosquito borne disease market. The development of new diagnostic tools, therapeutic drugs, and vaccines offers potential growth prospects. Moreover, collaborations and partnerships between pharmaceutical companies, research institutions, and governments are likely to accelerate the development of innovative solutions for mosquito control and prevention.

Key features of the study:

• This report provides in-depth analysis of the global mosquito borne disease market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global mosquito borne disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson, Eisai Co., Ltd, Takeda Pharmaceutical Company Limited, AstraZeneca, Valeant Pharmaceuticals International, Inc., Mitsubishi Tanabe Pharma Corporation, Abbott , F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Serum Institute of India Pvt. Ltd., CSL Limited, and Teva Pharmaceutical Industries Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global mosquito borne disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mosquito borne disease market

Global Mosquito Borne Disease Market Detailed Segmentation:

• By Disease Type
  • Malaria
  • Dengue
  • Yellow Fever
  • West Nile Virus
  • Chikungunya
  • Zika Virus
  • Others
• By Treatment Type
  • Medication
  • Vaccination
  • Vector Control Methods
  • Immunotherapy
  • Supportive Care
  • Others
• By End User
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Research Institutes
  • Government Organizations
  • NGOs
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Key Players:
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Johnson & Johnson
  • Eisai Co., Ltd
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • Valeant Pharmaceuticals International, Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Abbott
  • Hoffmann-La Roche Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Pharmaceuticals, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Mallinckrodt Pharmaceuticals
  • Serum Institute of India Pvt. Ltd.
  • CSL Limited
  • Teva Pharmaceutical Industries Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Mosquito Borne Disease, By Disease Type
  • Market Mosquito Borne Disease, By Treatment Type
  • Market Mosquito Borne Disease, By End User
  • Market Mosquito Borne Disease, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Mosquito Borne Disease Market, By Disease Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Malaria
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Dengue
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Yellow Fever
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• West Nile Virus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Chikungunya
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Zika Virus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Vaccination
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Vector Control Methods
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bin)
• Immunotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Supportive Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Government Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• NGOs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
• South Africa
• North Africa
• Central Africa

9. Competitive Landscape

• GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi S.A.
• Pfizer Inc.
• Merck & Co., Inc.
• Novartis AG
• Johnson & Johnson
• Eisai Co., Ltd
• Takeda Pharmaceutical Company Limited
• AstraZeneca
• Valeant Pharmaceuticals International, Inc.
• Mitsubishi Tanabe Pharma Corporation
• Abbott
• Hoffmann-La Roche Ltd
• Sun Pharmaceutical Industries Ltd
• Lupin Pharmaceuticals, Inc.
• BioCryst Pharmaceuticals, Inc.
• Mallinckrodt Pharmaceuticals
• Serum Institute of India Pvt. Ltd.
• CSL Limited
• Teva Pharmaceutical Industries Ltd
• Analyst Views

10. Section

• Research Methodology
• About us